VIRBAC: Revenue grew +6.8% at constant exchange rates and scope at the end of September 2020 (+5.6% at constant rates) thanks to solid third quarter performance
October 14, 2020 11:45 ET
|
Virbac
KEY FIGURESRevenueYear-to-date September 2020€713.9 millionTotal growth+2.4%(+3.3% excl. Sentinel)Growth at constant exchange rates+5.6% Growth at constant exchange rates and scope 1+6.8%...
Marel: Uppgjör þriðja ársfjórðungs 2020 birt 20. október, rafrænn afkomufundur 21. október 2020
October 13, 2020 11:02 ET
|
Marel hf.
Marel hf. mun birta uppgjör þriðja ársfjórðungs 2020 eftir lokun markaðar þann 20. október 2020. Rafrænn afkomufundur með markaðsaðilum Miðvikudaginn 21. október 2020 kl. 8:30 verður haldinn...
Marel: Q3 2020 results published on 20 October, virtual investor meeting on 21 October 2020
October 13, 2020 11:02 ET
|
Marel hf.
Marel hf. will publish its Q3 2020 interim condensed consolidated financial statements after market closing on 20 October 2020. Earnings conference call and webcast On Wednesday 21 October 2020, at...
GCC Announces Q3 2020 Conference Call Details
October 07, 2020 14:27 ET
|
Grupo Cementos De Chihuahua, S.A.B. De C.V.
CHIHUAHUA, Mexico, Oct. 07, 2020 (GLOBE NEWSWIRE) -- Grupo Cementos de Chihuahua, S.A.B. de C.V. (BMV: GCC*), a leading producer of cement and concrete in the United States and Mexico, will host a...
Notice of third quarter 2020 results and conference call
September 25, 2020 08:00 ET
|
Millicom International Cellular S.A.
Notice of third quarter 2020 results and conference call Luxembourg, September 25, 2020 – Millicom will announce its third quarter results on October 30, 2020 at approximately 11:00 (Stockholm)...
Minerva Neurosciences to Report Second Quarter 2020 Financial Results and Business Updates on August 3, 2020
July 27, 2020 08:00 ET
|
Minerva Neurosciences, Inc
WALTHAM, Mass., July 27, 2020 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (NASDAQ: NERV), a clinical-stage biopharmaceutical company focused on the development of therapies to treat central...